Antibiotics do not shorten tuberculosis treatment, finds Phase 3 trial
The results of a Phase 3 clinical trial involving UCL researchers, called REMoxTB, has found that replacing one of the drugs with the antibiotic moxifloxacin in the standard six-month treatment regimen did not allow the treatment time for tuberculosis (TB) patients to be shortened to four months. The trial confirmed the safety of daily moxifloxacin […]
